<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16856">Glutathione</z:chebi> is a central component in the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defences of cells </plain></SENT>
<SENT sid="1" pm="."><plain>We have recently reported an early and selective loss of total (reduced plus oxidised) <z:chebi fb="0" ids="16856">glutathione</z:chebi> from mitochondria isolated from rat brain following occlusion of the middle cerebral artery </plain></SENT>
<SENT sid="2" pm="."><plain>This <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="16856">glutathione</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath> showed an apparent association with the tissue damage that developed during subsequent reperfusion, suggesting that it could be an important determinant of susceptibility to cell loss </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we have investigated whether in vivo treatment with <z:chebi fb="0" ids="16856">glutathione</z:chebi> ethyl <z:chebi fb="21" ids="35701">ester</z:chebi> can modulate <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="16856">glutathione</z:chebi> in the brain and whether this treatment can influence the response to focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In further support of our previous findings, middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> caused a duration-dependent partial loss of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="16856">glutathione</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Bilateral injections of <z:chebi fb="0" ids="16856">glutathione</z:chebi> ethyl <z:chebi fb="21" ids="35701">ester</z:chebi> immediately prior to induction of unilateral focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> resulted in a substantial increase in <z:chebi fb="0" ids="16856">glutathione</z:chebi> in mitochondria from the striatum of both the non-ischemic hemisphere (190% of saline-treated controls) and the ischemic hemisphere (240% of controls) at 2h after <z:mp ids='MP_0006134'>arterial occlusion</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Total tissue <z:chebi fb="0" ids="16856">glutathione</z:chebi> was not affected by the <z:chebi fb="21" ids="35701">ester</z:chebi> treatment at this time </plain></SENT>
<SENT sid="7" pm="."><plain>A smaller increase in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="16856">glutathione</z:chebi> was observed at 3h of occlusion in the non-ischemic striatum following <z:chebi fb="21" ids="35701">ester</z:chebi> treatment but at this time point <z:chebi fb="0" ids="16856">glutathione</z:chebi> was not significantly altered in mitochondria from the ischemic hemisphere </plain></SENT>
<SENT sid="8" pm="."><plain>Pre-ischemic treatment with <z:chebi fb="0" ids="16856">glutathione</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> did not significantly change the volume of tissue infarction assessed at 48 h following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 2 or 3h </plain></SENT>
<SENT sid="9" pm="."><plain>These studies demonstrate that <z:chebi fb="0" ids="16856">glutathione</z:chebi> ethyl <z:chebi fb="21" ids="35701">ester</z:chebi> is a highly effective modulator of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="16856">glutathione</z:chebi> pool in the intact brain and provides a useful means for further investigating the role of this <z:chebi fb="11" ids="22586">antioxidant</z:chebi> in the development of tissue damage in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and other <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disorders</z:e> </plain></SENT>
</text></document>